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1. Introduction 
Ca2*-dependent modulator protein was discovered 
as an activator of phosphodiesterase [ 1,2], or a protein 
factor required for the Ca*+-dependent ac ivation of 
phosphodiesterase [3,4]. Later, this protein was 
shown to be structurally similar to troponin-C [5,6] 
and to cause Ca2+-dependent activation of several 
enzymes including phosphodiesterase, brain adenylate 
cyclase [7], myosin light chain kinases from skeletal 
muscles [g-10] and chicken gizzard muscle [ll], 
and actomyosin ATPase [ 12,131. Recently, two 
groups [14,15] have demonstrated that the activator 
protein [16,17] for the erythrocyte membrane 
ATPase is identical to this modulator protein. 
(Ca” t Mg2+)-ATPase activity was also found in 
brain tissue [ 18,191. However, requirement of brain 
enzyme for an activator has not been reported. In the 
present study, we are able to show the dependency of 
the activity of brain enzyme upon the modulator 
protein. Although brain (Ca2’ + Mg*‘)-ATPase activity 
was detected in all particulate fractions upon sub- 
cellular fractionation, only enzyme in the synaptic 
plasma membrane fraction was responsive to 
modulator protein. 
2. Materials and methods 
2.1. Preparation of synaptic membranes and other 
subcellular fractions 
Synaptic plasma membranes (P3_J and other sub- 
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cellular fractions were prepared from cerebral cortices 
of male Sprague Dawley rats as in [20] with a slight 
modification [191. Rat cerebral cortices were homog- 
enized with 10 vol. 0.32 M sucrose and centrifuged at 
900 X g for 10 min. The supernatant fluid was then 
centrifuged at 11 500 X g for 30 min. The resultant 
pellet (crude mitochondrial fraction) was further 
fractionated by sucrose density gradient centrifugations 
as shown in Bg.1. Nerve-ending particles were 
disrupted by hypotonic treatment as follows: the 
particulate material in fraction B was collected by 
centrifugation (105 000 X g for 60 min) then 
homogenized with water (2.5 ml water/g original 
tissue). Fractions A, C, P1_2, P3_4 and Ps_6 obtained 
as shown in fig.1 were suspended in 10 mM Tris-HCl 
(pH 7.5) and 1 mM EGTA and then centrifuged at 
105 000 X g for 60 min. This procedure was repeated 
once more: EGTA concentration i  the second time 
centrifugation was 100 fl instead of 1 mM. The 
Crude mitochondrial fraction 
I 
0.32M 
53500x g 
60 min 
Fig.1. Fractionation of crude mitochondrial fraction by 
sucrose gradient centrifugations. 
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resultant pellet, suspended in 10 mM Tris-HCl 
(pH 7.15)~ were used in the following study. All pre- 
parations were at 4°C. 
2.2.Analyticalprocedures 
(Ca2+ t Mg2”)-ATPase activity was determined as 
follows: 75 - 150 pg membrane protein was incubated 
at 37°C in a reaction mixture (0.8 ml) cont~ning 
50 mM Tris-HCl (PH 7.5), 2 mM MgC12, 100 mM 
KCl, 100 PM EGTA, 100 ,uM ouabain, 2 mM ATP and 
with (for total ATPase activity) or without (for 
Mg”-ATPase activity) the addition of 100 /.IM CaC12. 
Modulator protein (2.5 pg/tube) was added where 
indicated. After 30 mm incubation, the reaction was 
terminated by the addition of 0.2 ml 32% trichloro- 
acetic acid. The mixture was centrifuged and the 
supernatant was subjected to Pi determination as in 
[21]. (Ca2’ 4 Mg”)-ATPase activity was estimated as 
the difference between the activities of total ATPase 
and (Nd + IS’)-ATPase and succinate 
dehydrogenase (SDH) activities were determined as 
in [22] and [23], respectively. Modulator protein 
was assayed as in [24]. Protein was determined as in 
]251. 
3. Results and discussion 
Figure 2 shows the dependence of (Ca2* + Mg”)- 
ADDED Ca2+ (M) 
Fig.2. Effects of added Ca’+ and modulator protein on 
(Ca“ + Mg2’)-ATPase activity of synaptic plasma membranes. 
Synaptic plasma membrane samples which had been treated 
with EGTA (see section 2) was assayed for (Ca*’ + Mg”)- 
ATPase activity in the presence of 100 tiM EGTA and added 
Ca” as indicated with (0) or without (0) the addition of 
modulator protein. Bars represent standard deviation (n=4). 
ATPase activity of synaptic plasma membranes 
(P3_4) on additions of both Ca*+ and modulator 
protein. In the presence of 100 I.IM EGTA, activation 
of enzyme was observed with added Ca2+ at 
50-500 PM, the maximum activation being attained 
at -100 ,uM. With added Ca2+ at < 100 PM, say 
90&M, the free [Ca”‘] in the reaction medium was 
calculated to be in the order of < PM, taking Ca’+- 
EGTA & lo7 M-” [26]. Addition Ca2+ at > 500 PM 
was inhibitory. Addition of modulator protein 
increased enzyme activity by about 200%. The 
activation by modulator protein occurred over the 
entire [Ca”] range where Ca2’ was stimulatory to 
enzyme. In the absence of added Ca’*, addition of 
modulator protein produced no effect on enzyme 
activity, indicating that modulator protein does not 
affect Mg2’-ATPase. Modulator protein activated 
(Ca2+ t Mg”)-ATPase in a dose-dependent fashion 
(fig.3). Addition of 16 &g modulator proteinfmg 
synaptic plasma membrane protein produced a 
maximum effect. This amount of modulator protein 
is well in the physiological concentration range, 
because 1 g brain tissue contains - 500 pg modulator 
protein [24], and 30 mg of the total particulate 
protein. 
Fractions of PI_,, P3_4 and PS _6 consist of 
mainly myelin plus ribosomes, synaptic plasma 
MODULATOR PROTEIN ADDED 
fpg/mg of membran protein f 
Fig.3. Dependence of (Cal’ + Mg*+)-ATPase activity of 
synaptic plasma membranes on added modulator protein. 
The reaction mixture contained 100 PM EGTA and 100 PM 
CaCi,. 
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Table 1 
Enzyme activities in subcellular fractions 
Fraction (Ca’* + Mg*?-ATPase (Na’ + K’)-ATPase SDH 
Modulator(-) Modulator(+) (pmol.mg (A.mg prot.-‘. 
(Mmol.mg prot.-‘.h-‘) prot. -r-h-I ) 30 min-’ ) 
A 1.99 f 0.62 2.27 f 0.67 3.1 * 1.5 0.03 f 0.01 
C 0.80 + 0.23 0.84 * 0.20 6.6 f 0.4 0.45 * 0.05 
Pl-2 2.36 i 0.56 2.82 f 0.54 5.5 f 0.4 0.02 * 0.00 
P3-4 2.50 + 0.36a 4.98 f 0.42a 15 f 0.9 0.08 f. 0.08 
‘5 -6 2.02 t 0.66 2.53 + 0.34 4.8 ? 0.6 0.35 * 0.04 
ap < O.Ol,n=4 
membranes and synaptosomal mitochondria, 
respectively [ 19,221. In this study, fractions were 
monitored by measuring (Na’ + K’)-ATPase and 
succinate dehydrogenase (SDH) activities as markers 
for synaptic plasma membranes and mitochondria, 
respectively. The former was concentrated in P3_4 
fraction (table l), suggesting that the fraction P3_4 
was high in synaptic plasma membrane content. The 
latter was concentrated in both fractions C and 
P5_e (table 1). Although the activity of (Cal’ t Mg2’)- 
ATPase was distributed in all particulate fractions 
examined, modulator protein dependency of enzyme 
activity was seen only in P3_4. 
Unless precautions were taken to remove 
endogenous modulator protein from the membrane 
fractions by repeated cycles of the suspension of the 
membranes in EGTA solution and the subsequent 
centrifugation, the modulator protein dependency of 
enzyme activity could never be observed. We found 
that the levels of modulator protein in synaptic plasma 
membrane samples before and after the EGTA treat- 
ment were 3.6 pg and 0.9 pg, respectively, per mg 
membrane protein; the difference is the amount 
removed from the membranes by such treatment. The 
result is consistent with [24] reporting the occurrence of 
two forms of membrane-bound modulator protein in 
the brain: one form was removed from the membranes 
by EGTA treatment while the other form was not. It 
is possible that, in vivo, the activity of (Ca” t Mg23- 
ATPase is regulated by the membrane-bound 
modulator protein. There was an activity of (Ca” + 
Mg”)-ATPase that was independent of modulator 
protein addition (fig.2, table 1). Whether or not this 
is due to another species of enzyme is yet to be seen. 
A functional linkage of erythrocyte membrane 
(Ca’+ t Mg”)-ATPase with Ca2*-pump activity of 
the membranes was well documented [27,28]. There 
is some ambiguity for the role of the brain (Ca” t 
Mg2’)-ATPase (19,291: it may be related to the 
extrusion of Ca2+ to the extracellular space or the 
sequestration of intracellular Ca2+ by particulate 
components [30,31]. Moreover, it may be related to 
a system of actomyosin-like fibers which seem to be 
associated with synaptic structures [32,33]. 
Nevertheless, it is expected that the physiological 
function of Ca2+ in brain tissue will be elucidated to a 
large extent by further study on this enzyme in rela- 
tion with modulator protein. 
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